Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Margin 2010-2024 | MKKGY

Current and historical gross margin for Merck (MKKGY) over the last 10 years. The current gross profit margin for Merck as of December 31, 2024 is %.
  
Merck Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $22.89B $13.51B 59.01%
2024-09-30 $22.74B $13.33B 58.61%
2024-06-30 $22.58B $13.15B 58.23%
2024-03-31 $22.60B $13.12B 58.04%
2023-12-31 $22.72B $13.41B 59.03%
2023-09-30 $22.91B $13.76B 60.06%
2023-06-30 $23.13B $14.17B 61.26%
2023-03-31 $23.27B $14.40B 61.88%
2022-12-31 $23.42B $14.44B 61.64%
2022-09-30 $23.58B $14.70B 62.33%
2022-06-30 $23.60B $14.69B 62.24%
2022-03-31 $23.54B $14.69B 62.39%
2021-12-31 $23.29B $14.59B 62.66%
2021-09-30 $22.79B $14.20B 62.32%
2021-06-30 $22.12B $13.65B 61.71%
2021-03-31 $20.79B $12.73B 61.24%
2020-12-31 $20.03B $12.22B 61.02%
2020-09-30 $19.42B $11.87B 61.12%
2020-06-30 $18.73B $11.61B 62.00%
2020-03-31 $18.66B $11.68B 62.59%
2019-12-31 $18.09B $11.36B 62.82%
2019-09-30 $17.42B $10.98B 63.01%
2019-06-30 $17.27B $10.91B 63.15%
2019-03-31 $17.24B $10.93B 63.43%
2018-12-31 $17.52B $11.17B 63.72%
2018-09-30 $17.87B $11.47B 64.18%
2018-06-30 $17.90B $11.53B 64.43%
2018-03-31 $17.75B $11.49B 64.76%
2017-12-31 $17.32B $11.31B 65.30%
2017-09-30 $16.90B $11.10B 65.67%
2017-06-30 $16.68B $11.01B 65.99%
2017-03-31 $16.70B $11.00B 65.90%
2016-12-31 $16.63B $10.87B 65.38%
2016-09-30 $16.29B $10.71B 65.74%
2016-06-30 $15.63B $10.40B 66.53%
2016-03-31 $14.89B $10.02B 67.30%
2015-12-31 $14.31B $9.78B 68.38%
2015-09-30 $13.91B $9.36B 67.29%
2015-06-30 $14.32B $9.56B 66.73%
2015-03-31 $14.59B $9.81B 67.25%
2014-12-31 $14.78B $10.09B 68.26%
2014-09-30 $15.11B $10.64B 70.46%
2014-06-30 $14.86B $10.69B 71.98%
2014-03-31 $14.80B $10.77B 72.79%
2013-12-31 $14.72B $10.75B 73.02%
2013-09-30 $14.64B $11.73B 80.08%
2013-06-30 $14.55B $11.61B 79.77%
2013-03-31 $14.30B $11.32B 79.17%
2012-12-31 $14.00B $11.97B 85.54%
2012-09-30 $13.66B $11.64B 85.19%
2012-06-30 $13.69B $12.65B 92.42%
2012-03-31 $13.85B $12.75B 92.10%
2011-12-31 $14.08B $12.98B 92.23%
2011-09-30 $14.47B $13.38B 92.44%
2011-06-30 $14.03B $12.14B 86.50%
2011-03-31 $13.05B $12.25B 93.87%
2010-12-31 $12.34B $11.54B 93.52%
2010-09-30 $11.61B $10.81B 93.11%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.149B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.377B 32.78
Zoetis (ZTS) United States $74.051B 27.63
Takeda Pharmaceutical (TAK) Japan $48.270B 9.60
Daiichi Sankyo, - (DSNKY) Japan $47.264B 24.22
BeOne Medicines - (ONC) Cayman Islands $28.732B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.880B 0.00
Shionogi (SGIOY) Japan $14.717B 14.74
Summit Therapeutics (SMMT) United States $14.541B 0.00
United Therapeutics (UTHR) United States $12.471B 11.03
Neurocrine Biosciences (NBIX) United States $12.289B 42.09
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.501B 45.87
Madrigal Pharmaceuticals (MDGL) United States $6.535B 0.00
Grifols, S.A (GRFS) Spain $6.154B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.760B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Catalyst Pharmaceuticals (CPRX) United States $3.099B 10.86
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 13.19
NewAmsterdam Pharma (NAMS) Netherlands $2.302B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.220B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.195B 0.00
Indivior (INDV) United States $1.883B 7.99
Centessa Pharmaceuticals (CNTA) United Kingdom $1.668B 0.00
Dyne Therapeutics (DYN) United States $1.656B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.408B 0.00
Ocular Therapeutix (OCUL) United States $1.405B 0.00
Guardian Pharmacy Services (GRDN) United States $1.276B 0.00
Harrow (HROW) United States $1.160B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Enliven Therapeutics (ELVN) United States $0.962B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.957B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.15
Akebia Therapeutics (AKBA) United States $0.938B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Cronos Group (CRON) Canada $0.756B 0.00
Elite Pharmaceuticals (ELTP) United States $0.726B 0.00
Xeris Biopharma Holdings (XERS) United States $0.685B 0.00
Xencor (XNCR) United States $0.678B 0.00
KalVista Pharmaceuticals (KALV) United States $0.669B 0.00
AleAnna (ANNA) United States $0.587B 0.00
Relay Therapeutics (RLAY) United States $0.573B 0.00
Verve Therapeutics (VERV) United States $0.570B 0.00
Regulus Therapeutics (RGLS) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Bioventus (BVS) United States $0.551B 13.98
Theravance Biopharma (TBPH) United States $0.531B 0.00
Altimmune (ALT) United States $0.530B 0.00
Zevra Therapeutics (ZVRA) United States $0.513B 0.00
Tourmaline Bio (TRML) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.453B 9.46
Organogenesis (ORGO) United States $0.412B 0.00
Savara (SVRA) United States $0.380B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 10.24
Aquestive Therapeutics (AQST) United States $0.339B 0.00
Heron Therapeutics (HRTX) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.289B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
ProKidney (PROK) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.10
Esperion Therapeutics (ESPR) United States $0.240B 0.00
Nanobiotix S.A (NBTX) France $0.239B 0.00
MediWound (MDWD) Israel $0.223B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.198B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.170B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Lyell Immunopharma (LYEL) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.119B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Fractyl Health (GUTS) United States $0.111B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Inotiv (NOTV) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.087B 14.25
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.00
Nutriband (NTRB) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Jupiter Neurosciences (JUNS) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.060B 0.00
PMV Pharmaceuticals (PMVP) United States $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Avalo Therapeutics (AVTX) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
FibroGen (FGEN) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.025B 0.00
Carisma Therapeutics (CARM) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Ainos (AIMD) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00